When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. COVID-19 booster side effects: What to expect and how ... - AOL

   www.aol.com/news/covid-19-booster-side-effects...

   In a clinical trial involving about 300 people, the most common side effects after the Pfizer booster dose included: Pain, redness and swelling at the injection site. Fatigue.

3. How Long After Having COVID Should You Get the New Vaccine? - AOL

   www.aol.com/long-having-covid-vaccine-175600596.html

   The side effects are predicted to be similar to those of previous COVID-19 boosters. For instance, with last year's booster, the most common side effect was “a bit of a sore arm,” says William ...

4. Embolic and thrombotic events after COVID-19 vaccination

   en.wikipedia.org/wiki/Embolic_and_thrombotic...

   The thrombosis events associated with the COVID‑19 vaccine may occur 4–28 days after its administration and mainly affects women under 55. [6] [2] [20] Several relatively unusual types of thrombosis were specifically reported to be occurring in those with the reaction: cerebral venous sinus thrombosis and thrombosis of the splanchnic veins.

5. What Doctors Want You to Know About COVID-19 and Heart ... - AOL

   www.aol.com/doctors-want-know-covid-19-123000473...

   Of those, 2,000 were hospitalized with severe COVID between February 1, 2020, and December 31, 2020. As there were no vaccines available at the time, none of the patients were vaccinated.

6. Sanofi–GSK COVID-19 vaccine - Wikipedia

   en.wikipedia.org/wiki/Sanofi–GSK_COVID-19_vaccine

   The purpose of this study is to determine if the investigational COVID-19 vaccines are safe and can stimulate and broaden the immune response against the different COVID-19 variants that cause COVID-19 when given as a single booster injection in participants who have previously been vaccinated with a full course of an authorized COVID-19 vaccine.

7. Janssen COVID-19 vaccine - Wikipedia

   en.wikipedia.org/wiki/Janssen_COVID-19_vaccine

   After 57 days, that number reached one hundred percent. 1x10 11 viral particles (high dose) provided an increase in the neutralizing-antibody titers compared to 5×10 10 (low dose). After the second dose 56 days after the first dose among participants between the ages of 18 and 55 years, the incidence of grade 3 solicited systemic adverse ...